Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Elicitation of expert prior opinion to design the BARJDM trial in juvenile dermatomyositis.
Papadopoulou C, Martin N, Rafiq N, McCann L, Varner G, Nott K, Compeyrot-Lacassagne S, Leandro M, Foley C, Warrier K, Green N, Wan M, Dehbi HM, Whitehead J, Eleftheriou D, Brogan P. Papadopoulou C, et al. Among authors: compeyrot lacassagne s. Rheumatology (Oxford). 2024 Jul 29;63(12):3271-8. doi: 10.1093/rheumatology/keae392. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 39073903 Free PMC article.
Juvenile arthritis disease activity score is a better reflector of active disease than the disease activity score 28 in adults with polyarticular juvenile idiopathic arthritis.
Wu Q, Chaplin H, Ambrose N, Sen D, Leandro MJ, Wing C, Daly N, Webb K, Fisher C, Suffield L, Josephs F, Pilkington C, Eleftheriou D, Al-Obaidi M, Compeyrot-Lacassagne S, Wedderburn LR, Ioannou Y. Wu Q, et al. Ann Rheum Dis. 2016 Mar;75(3):635-6. doi: 10.1136/annrheumdis-2015-208462. Epub 2015 Dec 29. Ann Rheum Dis. 2016. PMID: 26715652 Free PMC article. No abstract available.
Inflammatory Arthritis as a Possible Feature of Coffin-Siris Syndrome.
Melo Gomes S, Dias C, Omoyinmi E, Compeyrot-Lacassagne S, Klein N, Sebire NJ, Brogan P. Melo Gomes S, et al. Among authors: compeyrot lacassagne s. Pediatrics. 2019 Jul;144(1):e20181741. doi: 10.1542/peds.2018-1741. Pediatrics. 2019. PMID: 31243159
Identification and prediction of novel classes of long-term disease trajectories for patients with juvenile dermatomyositis using growth mixture models.
Deakin CT, Papadopoulou C, McCann LJ, Martin N, Al-Obaidi M, Compeyrot-Lacassagne S, Pilkington CA, Tansley SL, McHugh NJ, Wedderburn LR, De Stavola BL; Juvenile Dermatomyositis Research Group. Deakin CT, et al. Among authors: compeyrot lacassagne s. Rheumatology (Oxford). 2021 Apr 6;60(4):1891-1901. doi: 10.1093/rheumatology/keaa497. Rheumatology (Oxford). 2021. PMID: 33146389 Free PMC article.
Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis.
Ramanan AV, Dick AD, Jones AP, McKay A, Williamson PR, Compeyrot-Lacassagne S, Hardwick B, Hickey H, Hughes D, Woo P, Benton D, Edelsten C, Beresford MW; SYCAMORE Study Group. Ramanan AV, et al. N Engl J Med. 2017 Apr 27;376(17):1637-1646. doi: 10.1056/NEJMoa1614160. N Engl J Med. 2017. PMID: 28445659 Free article. Clinical Trial.
27 results